Over the last few months, PETNET Solutions undertook some important market research of customers and members of the nuclear medicine community by utilising the popular Survey Monkey online web tool.
A 26-question survey was designed, road tested and then emailed to approximately 200 select individuals. Responses were anonymous.
The aim of the questionnaire was to gather important customer feedback to help PETNET Solutions provide better customer service and better tailor a product range to reflect the needs of the nuclear medicine community.
Respondents were encouraged to participate in the research with a $50 charity incentive for every survey completed. Respondents had the choice of the money being donated to either their preferred charity or to Linking the Links, PETNET Solutions’ charity partner.
Overall, the response rate was very impressive and the results equally enlightening. It was very clear ‘reliability’ and ‘price’ were the two key criteria voted for by customers as critical in their choice of a radiopharmaceutical supplier. ‘Educational support’ was also considered ‘very important’ by 63.6 per cent of respondents.
The majority of respondents indicated 18F FLT, followed by 18F DOPA as the two key biomarkers of interest for investigative work in the future. In addition, 50 per cent of respondents were interested in having access to sodium fluoride for a nominated day of the week.
Customers prefer a ‘partnership’ rather than ‘business’ relationship with their supplier with regular email updates, company newsletters and industry conferences considered the most effective means of corporate communication.
Along with generous donations to Linking the Links, PETNET Solutions’ charity partner other charities that received $50 donations include the St Vincent’s & Mater Health Unit, Sydney, UNICEF, The Australian Red Cross, Ray of Hope (breast cancer charity at Westmead Hospital Sydney), Cat Protection Society NSW, Enmore and the Juvenile Diabetes Research Foundation.
A big thank you to all those who responded to our survey.